| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(98)03202-4 |
| P698 | PubMed publication ID | 9843102 |
| P2093 | author name string | N R Hicks | |
| P A Boyd | |||
| P Chamberlain | |||
| P2860 | cites work | Effectiveness of routine ultrasonography in detecting fetal structural abnormalities in a low risk population | Q35181464 |
| Value of routine ultrasound scanning at 19 weeks: a four year study of 8849 deliveries | Q35821867 | ||
| Antenatal screening for Down's syndrome. | Q40909255 | ||
| Impact of prenatal screening and diagnosis on the epidemiology of structural congenital anomalies | Q41007905 | ||
| Ultrasound screening for fetal abnormalities. | Q41034978 | ||
| Screening could seriously damage your health | Q42782072 | ||
| Ultrasonographic "soft markers" of fetal chromosomal defects | Q42782797 | ||
| First trimester fetal nuchal translucency: problems with screening the general population. 1. | Q47337190 | ||
| Fetal abnormality: an audit of its recognition and management. Northern Regional Survey Steering Group | Q68038182 | ||
| Evaluation of routine prenatal diagnosis by a registry of congenital anomalies | Q70895612 | ||
| Fetal anomalies in a controlled one-stage ultrasound screening trial. A report from the Helsinki Ultrasound Trial | Q72594698 | ||
| Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancy | Q72772971 | ||
| The influence of prenatal ultrasound on the prevalence of congenital anomalies at birth | Q73569740 | ||
| Assessment of fetal nuchal translucency test for Down's syndrome | Q73699522 | ||
| Fetal nuchal translucency test for Down's syndrome | Q73931000 | ||
| P433 | issue | 9140 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1577-1581 | |
| P577 | publication date | 1998-11-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | 6-year experience of prenatal diagnosis in an unselected population in Oxford, UK. | |
| P478 | volume | 352 |
| Q33744067 | Aiming for perfection: outcome of fetal and neonatal medicine |
| Q57751342 | Amyoplasia involving only the upper limbs or only involving the lower limbs with review of the relevant differential diagnoses |
| Q57751348 | Amyoplasia revisited |
| Q36365349 | Antenatal transabdominal ultrasound detection of cleft lip and palate in Western Australia from 1996 to 2003. |
| Q57751374 | Arthrogryposis (multiple congenital contractures) associated with failed termination of pregnancy |
| Q42692700 | Audit of prenatal and postnatal diagnosis of isolated open spina bifida in three university hospitals in The Netherlands. |
| Q79367165 | Audit: women's perception and knowledge of the 20 weeks anomaly scan |
| Q35132140 | Autopsy after termination of pregnancy for fetal anomaly: retrospective cohort study |
| Q85005304 | Cleft Lip/Palate: Incidence of Prenatal Diagnosis in Glasgow, Scotland, and Comparison with Other Centers in the United Kingdom |
| Q85211983 | Comparison of first and second trimester ultrasound screening for fetal anomalies in the southeast region of Sweden |
| Q52133452 | Coordinated ultrasound screening of infants: Hungary experience. |
| Q81931278 | Decision-making after ultrasound diagnosis of fetal abnormality |
| Q40550965 | Detection of fetal abnormalities by second-trimester ultrasound screening in a non-selected population |
| Q35931345 | Epidemiologic Research on Malformations Associated with Cleft Lip and Cleft Palate in Japan |
| Q77884348 | Evaluation and evolution during time of prenatal diagnosis of congenital heart diseases by routine fetal ultrasonographic examination |
| Q73807854 | Evaluation of prenatal diagnosis of cleft lip/palate by foetal ultrasonographic examination |
| Q78377321 | Impact of prenatal diagnosis on livebirth prevalence of children with congenital anomalies |
| Q51907407 | MRI for definitive in utero diagnosis of cleft palate: a useful adjunct to antenatal care? |
| Q34914300 | Neural tube defects: prevalence, etiology and prevention |
| Q77745686 | Perinatal testing. Testing times for pregnant women |
| Q37141479 | Pregnancy continuation and organizational religious activity following prenatal diagnosis of a lethal fetal defect are associated with improved psychological outcome |
| Q44169564 | Preliminary results on pregnancy outcomes in women using lamotrigine |
| Q35597661 | Prenatal diagnosis of congenital anomalies |
| Q33876578 | Prenatal screening |
| Q40386359 | Prenatal screening for fetal face and clefting in a prospective study on low-risk population: can 3- and 4-dimensional ultrasound enhance visualization and detection rate? |
| Q43786283 | Prenatal sonographic detection of birth defects in 18 hospitals from South America |
| Q35297543 | Prevalence of congenital anomalies in five British regions, 1991-99. |
| Q80839023 | Psychological distress in parents of children with severe congenital heart disease: the impact of prenatal versus postnatal diagnosis |
| Q37303883 | Randomised controlled trial comparing effectiveness of touch screen system with leaflet for providing women with information on prenatal tests |
| Q79793897 | Seeing baby: women's experience of prenatal ultrasound examination and unexpected fetal diagnosis |
| Q28396364 | Spina bifida |
| Q42784497 | Terminology for our times: others will have similar examples |
| Q34530442 | The accuracy of antenatal ultrasound in the detection of facial clefts in a low-risk screening population |
| Q38016971 | The evolution of prenatal screening and diagnosis and its impact on an unselected population over an 18-year period |
| Q46632598 | The variability in the interpretation of prenatal diagnostic ultrasound |
| Q37119113 | Time to reconsider our approach to echogenic intracardiac focus and choroid plexus cysts |
| Q34618578 | Ultrasound in prenatal diagnosis: polemics around routine ultrasound screening for second trimester fetal malformations |
| Q30917622 | Ultrasound screening in pregnancy: advancing technology, soft markers for fetal chromosomal aberrations, and unacknowledged ethical dilemmas |
| Q48359204 | Use of a confidence scale in reporting postmortem fetal magnetic resonance imaging |
| Q80361819 | [Role of "subtle" ultrasonographic signs during antenatal screening for trisomy 21 during the second trimester of pregnancy: meta-analysis and CPDPN protocol of the Grenoble University Hospital] |
Search more.